Caira, Morena
 Distribuzione geografica
Continente #
EU - Europa 3.503
NA - Nord America 2.638
AS - Asia 1.831
SA - Sud America 304
AF - Africa 33
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.318
Nazione #
US - Stati Uniti d'America 2.589
DE - Germania 1.917
SG - Singapore 860
CN - Cina 609
SE - Svezia 362
UA - Ucraina 330
BR - Brasile 251
FR - Francia 156
PL - Polonia 154
GB - Regno Unito 143
IT - Italia 139
IE - Irlanda 108
FI - Finlandia 69
ID - Indonesia 68
IN - India 63
RU - Federazione Russa 63
VN - Vietnam 61
TR - Turchia 44
MX - Messico 29
AR - Argentina 25
IQ - Iraq 20
JP - Giappone 19
BD - Bangladesh 18
CA - Canada 15
HK - Hong Kong 15
ZA - Sudafrica 13
BE - Belgio 11
NL - Olanda 9
SA - Arabia Saudita 9
EC - Ecuador 8
ES - Italia 8
PK - Pakistan 8
UZ - Uzbekistan 8
CO - Colombia 6
VE - Venezuela 6
AU - Australia 5
CI - Costa d'Avorio 5
KE - Kenya 5
AT - Austria 4
CL - Cile 4
HU - Ungheria 4
IL - Israele 4
KZ - Kazakistan 4
LT - Lituania 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CH - Svizzera 3
EG - Egitto 3
KR - Corea 3
NG - Nigeria 3
BN - Brunei Darussalam 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EU - Europa 2
GR - Grecia 2
IR - Iran 2
MA - Marocco 2
MD - Moldavia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
RO - Romania 2
UY - Uruguay 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
ME - Montenegro 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 8.318
Città #
Chandler 474
Singapore 356
Ashburn 254
Jacksonville 196
Warsaw 147
San Mateo 145
Nürnberg 120
Dublin 107
Ann Arbor 102
Beijing 94
Dearborn 94
Nanjing 91
Woodbridge 76
Wilmington 72
New York 71
Jakarta 64
Bremen 63
Lawrence 56
Boston 52
Hefei 50
Houston 50
Munich 47
Los Angeles 46
Moscow 42
Nanchang 40
Zhengzhou 39
Milan 38
Izmir 34
Seattle 32
Fairfield 31
Buffalo 30
Marseille 30
São Paulo 27
Lancaster 25
Kunming 24
Frankfurt am Main 23
Ho Chi Minh City 22
University Park 22
Hebei 20
Tianjin 20
Shenyang 19
Redwood City 18
Hanoi 17
Mountain View 17
Shanghai 16
Boardman 15
Hong Kong 15
Jiaxing 15
Changsha 14
Cuauhtémoc 14
Kent 14
Philadelphia 14
Leawood 12
Rome 12
Tokyo 12
Brussels 11
Cambridge 10
Guangzhou 10
Hangzhou 10
Pune 10
Fremont 9
Porto Alegre 9
Auburn Hills 8
Baghdad 8
Santa Clara 8
Costa Mesa 7
Düsseldorf 7
Kraków 7
Mexico City 7
Norwalk 7
Nuremberg 7
Princeton 7
Rio de Janeiro 7
Cattolica 6
Chicago 6
Dallas 6
London 6
Phoenix 6
Tashkent 6
Toronto 6
Abidjan 5
Augusta 5
Belo Horizonte 5
Brooklyn 5
Campinas 5
Indiana 5
Jinan 5
Riyadh 5
Salvador 5
San Francisco 5
Taizhou 5
Amsterdam 4
Brasília 4
Budapest 4
Charlotte 4
Contursi Terme 4
Curitiba 4
Guarulhos 4
Henderson 4
Joinville 4
Totale 3.832
Nome #
Incidence of acute myeloid leukemia after breast cancer 362
Factors associated with mortality in bacteremic patients with hematologic malignancies. 342
Factors associated with mortality in bacteremic patients with haematologic malignancies 337
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 332
A prospective survey of febrile events in hematological malignancies 288
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. 204
Factors associated with mortality in bacteremic patients with hematologic malignancies. 203
Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia. 185
Increased production of gliotoxin is related to the formation of biofilm byAspergillus fumigatus: an immunological approach 181
Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay 180
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. 172
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 171
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 164
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 148
Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 142
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 142
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). 141
A prospective survey of febrile events in hematological malignancies 137
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 134
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry 130
A prospective survey of febrile events in hematological malignancies 130
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 129
Hema e-Chart: Italian Registry for prospective analysis of epidemiology, management and outcome of febrile events in patients with hematological malignancies 128
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 128
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 128
Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry 127
Advanced mast cell disease: an Italian Hematological Multicenter experience. 126
Granulocyte transfusions as adjunctive treatment of invasive fungal diseases in neutropenic patients 126
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 125
A patient with acute myeloid leukemia and a solid mass in the colon. 123
Uncommon yeast infections in hematological patients: from diagnosis to treatment 120
SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients 119
First case of breakthrough pneumonia due to Aspergillus nomius in a patient with acute myeloid leukemia 113
Scedosporiosis in patients with acute leukemia: a retrospective multicenter report 113
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies 111
Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality--SEIFEM-C Report. 110
Caspofungin for the treatment of candidaemia in patients with haematological malignancies 106
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project 104
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 103
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 101
A prospective, multicentre survey on antifungal therapy in neutropenic paediatric haematology patients 101
Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey 101
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies 100
Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B? 100
The role of primary antifungal prophylaxis in patients with haematological malignancies 98
The role of Gemtuzumab Ozogamicin in the treatment of acute myeloid leukemia patients. 97
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 96
Uncommon mold infections in hematological patients: epidemiology, diagnosis and treatment 93
Current therapeutic approaches to fungal infections in immunocompromised hematological patients 89
Evaluation of the Practice of Antifungal Prophylaxis Use in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results From the SEIFEM 2010-B Registry 88
Genetic PTX3 Deficiency and Aspergillosis in Stem-Cell Transplantation 88
Invasive fungal infections in patients with acute myeloid leukcemia and in those submitted to allogenic hemopoietic stem cell transplant: Who is at highest risk?. 86
Etiology of Febrile Episodes in Patients With Acute Myeloid Leukemia: Results From the Hema e-Chart Registry 86
The role of neutrophils in the development and outcome of zygomycosis in haematological patients 81
ZYGOMYCOSIS: Current approaches to management of patients with haematological malignancies. 77
. Pulmonary aspergillosis: lights and shadows 76
Combined voriconazole plus caspofungin therapy for the treatment of probable Geotrichum pneumonia in a leukemia patient 71
Hema e-Chart Registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections 70
The management of febrile neutropenia in the posaconazole era: a new challenge? 61
Italian Hema e-Chart Group.Continuous surveillance of invasive fungal infection: a realistic goal for the near future. 59
Invasive aspergillosis in acute leukemias: old and new risk factors and epidemiological trends 57
Risks for infection in patients with myelodysplasia and acute leukemia 56
Uncommon yeast infections in hematological patients: from diagnosis to treatment 52
Totale 8.348
Categoria #
all - tutte 29.923
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.923


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021371 0 0 0 0 0 38 89 16 74 18 126 10
2021/2022561 72 60 7 24 16 11 13 86 25 42 71 134
2022/20231.207 123 174 109 224 92 163 45 104 138 5 25 5
2023/2024439 32 155 6 8 14 70 33 8 4 9 62 38
2024/2025934 40 36 67 15 104 32 15 43 190 69 169 154
2025/20261.269 386 61 132 205 458 27 0 0 0 0 0 0
Totale 8.348